Healthcare

Shares of German biotechnology firm BioNTech faced renewed pressure on Friday following a media report examining potential COVID-19 vaccine side...

Merck KGaA's recent $3.9 billion acquisition of SpringWorks Therapeutics is demonstrating immediate strategic value, with European regulators granting marketing authorization...

While numerous healthcare companies face ongoing challenges with cost pressures and complex regulations, Privia Health has demonstrated how a value-based...

The investment landscape surrounding healthcare distributor McKesson presents a fascinating divergence of opinion. While major institutional players are building significant...

The Cooper Companies' latest quarterly earnings have placed its shares under the microscope. While the medical device manufacturer demonstrated solid...

The telehealth provider Hims & Hers finds itself navigating turbulent regulatory waters. Its recent expansion into the multi-billion dollar testosterone...

Investors are reassessing Viking Therapeutics' clinical trial data as concerns emerge about patient discontinuation rates in the study of oral...

Despite delivering a series of positive developments, including new product launches and robust quarterly results, OrthoPediatrics shares are experiencing significant...

Medical device specialist Utah Medical Products is confronting significant headwinds, with its latest quarterly results revealing a pronounced contraction in...

Telehealth provider Hims & Hers Health is making a bold strategic move to capture a significant share of the lucrative...